CBT improves blood sugar in diabetes patients with sleep problems: Study Medha Baranwal2 Oct 2020 12:00 PM ISTUSA: Cognitive Behavioral Therapy for Insomnia (CBT-I) has a positive impact on blood sugar control in people with type 2 diabetes (T2D) and insomnia...
Sitagliptin improves survival in diabetes patients with COVID-19: Study Dr. Kamal Kant Kohli30 Sept 2020 11:00 AM ISTBOSTON - Researchers have found in a new multicenter observational study in Italy that Sitagliptin, a Diabetes drug improves survival in diabetes...
Regular use of PPIs tied to heightened risk of type 2 diabetes: BMJ study Hina Zahid29 Sept 2020 11:15 AM ISTProton pump inhibitors (PPIs) are used to treat acid reflux, peptic ulcers, and indigestion. They are among the top 10 most commonly used drugs...
Two groups of blood sugar control drugs significantly reduce CKD and CVD risk- AHA Dr. Kamal Kant Kohli29 Sept 2020 8:00 AM ISTDALLAS - Two newer groups of antidiabetic medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor...
Galectin-3 can predict CVD risk in diabetes patients: ESC 2020 Medha Baranwal28 Sept 2020 7:00 PM ISTSpain: Plasma levels of galectin-3 can help in the prediction of cardiovascular events in patients with type 2 diabetes (T2D) suggests a recent study...
Heart disease in young linked to Intrauterine exposure to diabetes: Study Hina Zahid28 Sept 2020 6:40 PM ISTResearchers have found in a new study that Heart disease in adults and teenagers may be linked to Intrauterine exposure to diabetes.The new research...
Semaglutide effectively manages blood sugar and kidney function in diabetes: Lancet Dr Satabdi Saha28 Sept 2020 12:00 PM ISTPatients with type 2 diabetes have increased risk of developing chronic kidney disease. Researchers conducted a study to examine the effects of...
Remission of type 2 diabetes can restore pancreas size and shape, reveals study Hina Zahid28 Sept 2020 11:38 AM ISTIn 2019, research revealed that achieving remission of type 2 diabetes by intensive weight loss can restore the insulin-producing capacity of the...
Dapagliflozin reduces Renal Risk in CKD, irrespective of Diabetes Status: NEJM Dr Satabdi Saha25 Sept 2020 8:58 PM ISTThe sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk for kidney disease progression and death in patients with chronic...
Type 1 diabetes reduces lifespan by 8 years and type 2 diabetes by 2 years, claims study Hina Zahid25 Sept 2020 11:30 AM ISTA new modelling study presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year,...
Poor blood sugar control in diabetes tied to housing instability, finds study Dr. Kamal Kant Kohli25 Sept 2020 4:00 AM ISTResearchers have found in a cross-sectional study that moving once a year or more is linked with poor blood sugar control in people with type 2...
SGLT2 Inhibitors tied to lower CV risk relative to DPP-4 Inhibitors in Diabetes: BMJ Dr. Kamal Kant Kohli24 Sept 2020 9:56 AM ISTPrevious trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with...
